Alpha Tau Medical R&D Spending Growth & History (DRTS)

Alpha Tau Medical's r&d spending was $32.1M for fiscal 2025.

View full Alpha Tau Medical company overview

Alpha Tau Medical annual r&d spending history

Alpha Tau Medical annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$32.1M$5.0M+18.67%
20242024-12-31$27.0M$596,000+2.26%
20232023-12-31$26.4M$5.5M+26.49%
20222022-12-31$20.9M$9.4M+82.49%
20212021-12-31$11.4M$3.9M+51.74%
20202020-12-31$7.5M$908,000+13.68%
20192019-12-31$6.6M

Alpha Tau Medical r&d spending trends

Over the last five fiscal years, Alpha Tau Medical's r&d spending increased from $7.5M to $32.1M, a change of $24.5M. The latest reported quarter, Q2 2026, shows $9.9M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Alpha Tau Medical source filings ↗

Community posts

It’s quiet here.

No posts about DRTS yet. Start the conversation.

Write the first post